- Home
- GDTC vs EPOW Comparison
GDTC vs EPOW Comparison
Compare GDTC & EPOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- EPOW
- Stock Information
- Founded
- GDTC 2018
- EPOW 2014
- Country
- GDTC Singapore
- EPOW China
- Employees
- GDTC N/A
- EPOW N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- EPOW Business Services
- Sector
- GDTC Health Care
- EPOW Consumer Discretionary
- Exchange
- GDTC Nasdaq
- EPOW Nasdaq
- Market Cap
- GDTC 21.5M
- EPOW 24.8M
- IPO Year
- GDTC 2023
- EPOW 2021
- Fundamental
- Price
- GDTC $1.89
- EPOW $0.90
- Analyst Decision
- GDTC Buy
- EPOW
- Analyst Count
- GDTC 1
- EPOW 0
- Target Price
- GDTC $5.00
- EPOW N/A
- AVG Volume (30 Days)
- GDTC 18.1K
- EPOW 16.4K
- Earning Date
- GDTC 01-01-0001
- EPOW 08-05-2025
- Dividend Yield
- GDTC N/A
- EPOW N/A
- EPS Growth
- GDTC N/A
- EPOW N/A
- EPS
- GDTC N/A
- EPOW N/A
- Revenue
- GDTC $368,838.00
- EPOW $64,997,741.00
- Revenue This Year
- GDTC $5.37
- EPOW N/A
- Revenue Next Year
- GDTC N/A
- EPOW N/A
- P/E Ratio
- GDTC N/A
- EPOW N/A
- Revenue Growth
- GDTC N/A
- EPOW 44.28
- 52 Week Low
- GDTC $1.20
- EPOW $0.55
- 52 Week High
- GDTC $4.05
- EPOW $1.36
- Technical
- Relative Strength Index (RSI)
- GDTC 37.08
- EPOW 46.09
- Support Level
- GDTC $1.85
- EPOW $0.87
- Resistance Level
- GDTC $1.95
- EPOW $0.95
- Average True Range (ATR)
- GDTC 0.10
- EPOW 0.04
- MACD
- GDTC -0.02
- EPOW -0.00
- Stochastic Oscillator
- GDTC 28.00
- EPOW 19.54
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.